Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Is microdosing tirzepatide supported by clinical evidence
One order, one HPLC-verified set, ready for combined-activity and cross-pathway studies without sourcing and reconstituting each compound separately
The hormone stimulates glucose-dependent insulin secretion from pancreatic beta cells, meaning insulin release occurs only when blood glucose levels are elevated
Technical Information Compound Name: Tirzepatide Peptide Classification: Dual GIP/GLP-1 Receptor Agonist Molecular Formula: CHNO Appearance: White to off-white lyophilized powder Solubility: Typically soluble in bacteriostatic water or suitable research-grade diluents Research Category: Metabolic and incretin-pathway research peptide Common Research Areas GIP and GLP-1 receptor signaling Glucose-homeostasis investigations Appetite and satiety-related research Adipose and metabolic-regulation studies Cardiometabolic and obesity-related research Endocrine and energy-balance pathway investigations For Laboratory and Research Use Only Not for human consumption or therapeutic use
Brain Sci 10(3):163
US$ 26.07
US$ 21.75
US$ 21.39
